Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Routine antibiotic prophylaxis for EUS-FNA of solid pancreatic lesions (ceftriaxone vs no prophylaxis)
ChiCTR2000039859Phase 3Recruiting
- Sponsor
- Fudan University Shanghai Cancer Center
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of ceftriaxone (2 arms), sponsored by Fudan University Shanghai Cancer Center. Primary endpoints: Blood routine examination and C-reactive protein (CRP). Started Nov 2020; status: recruiting.
02
Drugs
ceftriaxone
Beyond the preview
Go deeper on ChiCTR2000039859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039859.